Lee Ainslie Caribou Biosciences, Inc. Transaction History
Maverick Capital LTD
- $5.04 Billion
- Q1 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 652,542 shares of CRBU stock, worth $1.88 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
652,542
Previous 652,542
-0.0%
Holding current value
$1.88 Million
Previous $3.74 Million
10.3%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
158Shares Held
67.4MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$20.2 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$18.7 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$18.3 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$16.7 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.11MShares$11.8 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $175M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...